{"id":3954,"date":"2024-01-03T13:06:03","date_gmt":"2024-01-03T13:06:03","guid":{"rendered":"https:\/\/www.msd.cz\/en\/?page_id=3954"},"modified":"2024-05-02T09:08:17","modified_gmt":"2024-05-02T09:08:17","slug":"product-information-draft","status":"publish","type":"page","link":"https:\/\/www.msd.cz\/en\/product-information-draft\/","title":{"rendered":"Product information – draft"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t\n\t\t\t

Product Information<\/h2>\n\n\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n

Table of Products<\/strong><\/h2>\n\n\n\n

We invest billions of research dollars to find medicines that can help improve lives. We provide a range of prescription products in key therapeutic areas such as oncology, immunology, vaccines, infectious diseases, diabetology, cardiology and anesthesiology.<\/p>\n\n\n\n

Adempas <\/strong>(riociguat)<\/p>\n\n\n\n

Bridion <\/strong>(sugammadex sodium)<\/p>\n\n\n\n

Cancidas<\/strong> (caspofungin diacetate)<\/p>\n\n\n\n

Cubicin<\/strong> (daptomycin)<\/p>\n\n\n\n

Delstrigo<\/strong> (doravirine, lamivudine, tenofovir disoproxil fumarate)<\/p>\n\n\n\n

Efficib<\/strong> (sitagliptin phosphate monohydrate, metformin hydrochloride)<\/p>\n\n\n\n

Emend<\/strong> (aprepitant)<\/p>\n\n\n\n

Ervebo<\/strong> (Ebola Zaire virus rVSV\u2206G-ZEBOV-GP, live, attenuated)<\/p>\n\n\n\n

Esmeron<\/strong> (rocuronium bromide)<\/p>\n\n\n\n

Gardasil 9<\/strong> (L1 protein human papillomavirus type 6, 11, 16, 18, 31, 33, 45, 52 and 58)<\/p>\n\n\n\n

HBVAXPRO<\/strong> (surface antigen of Hepatitis B, recombinant)<\/p>\n\n\n\n

Invanz<\/strong> (ertapenem)<\/p>\n\n\n\n

Isentress<\/strong> (raltegravir potassium)<\/p>\n\n\n\n

Ivemend<\/strong> (fosaprepitant dimeglumine)<\/p>\n\n\n\n

Janumet<\/strong> (sitagliptin phosphate monohydrate, metformin hydrochloride)<\/p>\n\n\n\n

Januvia<\/strong> (sitagliptin phosphate monohydrate)<\/p>\n\n\n\n

Keytruda<\/strong> (pembrolizumab)<\/p>\n\n\n\n

Lagevrio<\/strong> (molnupiravir)<\/p>\n\n\n\n

Lyfnua<\/strong> (gefapixant citrate)<\/p>\n\n\n\n

M-M-RVAXPRO<\/strong> (Measles, Mumps and Rubella viruses, live, attenuated)<\/p>\n\n\n\n

Noxafil<\/strong> (posaconazole)<\/p>\n\n\n\n

Pifeltro<\/strong> (doravirine)<\/p>\n\n\n\n

Pneumovax23<\/strong> (streptococcus pneumoniae serotype 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19f, 19a, 20, 22f, 23f and 33f polysaccharides)<\/p>\n\n\n\n

Prevymis<\/strong> (letermovir)<\/p>\n\n\n\n

ProQuad<\/strong> (Measles, Mumps and Rubella and Varicella viruses, live, attenuated)<\/p>\n\n\n\n

Recarbrio<\/strong> (imipenem monohydrate, cilastatin sodium, relebactam monohydrate)<\/p>\n\n\n\n

Remicade<\/strong> (infliximab)<\/p>\n\n\n\n

Ristaben<\/strong> (sitagliptin phosphate monohydrate)<\/p>\n\n\n\n

Ristfor<\/strong> (sitagliptin phosphate monohydrate, metformin hydrochloride)<\/p>\n\n\n\n

RotaTeq<\/strong> (rotavirus serotype G1, G2, G3, G4 and P1A[8], live)<\/p>\n\n\n\n

Segluromet<\/strong> (ertugliflozin pidolic acid, metformin hydrochloride)<\/p>\n\n\n\n

Simponi<\/strong> (golimumab)<\/p>\n\n\n\n

Sivextro<\/strong> (disodium tedizolid phosphate)<\/p>\n\n\n\n

Stocrin<\/strong> (efavirenz)<\/p>\n\n\n\n

Steglujan<\/strong> (ertugliflozin pidolic acid, sitagliptin phosphate monohydrate)<\/p>\n\n\n\n

Steglatro<\/strong> (ertugliflozin pidolic acid)<\/p>\n\n\n\n

Temodal<\/strong> (temozolomide)<\/p>\n\n\n\n

Tesavel<\/strong> (sitagliptin phosphate monohydrate)<\/p>\n\n\n\n

Vaxneuvance<\/strong> (pneumococcal polysaccharide serotype 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 22f, 23f and 33f, conjugated)<\/p>\n\n\n\n

Vaqta<\/strong> (Hepatitis A virus, inactivated)<\/p>\n\n\n\n

Varivax<\/strong> (Varicella virus, live, attenuated)<\/p>\n\n\n\n

Vaxelis<\/strong> (Diphtheria Toxoid, Tetanus Toxoid, Bordetella pertussis antigens (Pertussis Toxoid (PT)), Filamentous Haemagglutinin (FHA), Pertactin (PRN)s, Fimbriae Types 2 and 3 (FIM), Hepatitis B surface antigen, Poliovirus type 1, 2, 3 (inactivated), Haemophilus influenzae type b polysaccharide conjugated)<\/p>\n\n\n\n

Velmetia<\/strong> (sitagliptin phosphate monohydrate, metformin hydrochloride)<\/p>\n\n\n\n

Xelevia<\/strong> (sitagliptin phosphate monohydrate)<\/p>\n\n\n\n

Zepatier<\/strong> (elbasvir, grazoprevir)<\/p>\n\n\n\n

Zerbaxa<\/strong> (ceftolozane sulphate, tazobactam sodium)<\/p>\n\n\n\n

Zinplava<\/strong> (bezlotoxumab)<\/p>\n\n\n\n

Zostavax<\/strong> (Varicella virus, live, attenuated)<\/p>\n\n\n\n

<\/div>\n\n\n\n

VPOIS<\/strong><\/h2>\n\n\n\n

You have entered a public section, which contains information on all medicinal products of the marketing authorization holders represented by Merck Sharp & Dohme s.r.o.<\/p>\n\n\n\n

The obligation to establish this \u201cPublicly Accessible Professional Information Service \u2013 VPOIS\u201d follows from Act No. 378\/2007 Coll., On Pharmaceuticals, as amended (Section 33 (3) (g) (1)). For up-to-date information on individual products, their reimbursement and availability, please visit the medicines database here<\/a> on the website of the State Institute for Drug Control.<\/p>\n\n\n\n

Product information (Summary of Product Characteristics or Package Leaflet) can best be found in the database by entering the name of the product in the search field on the Medicines by MA number<\/strong> tab, clicking on Search<\/strong> and then clicking on the line corresponding to the desired product.<\/p>\n\n\n\n

Information about the reimbursement and availability on the market can best be found in the database by entering the name of the product in the search field on the Medicines by S\u00daKL code<\/strong> tab, clicking on Search<\/strong> and then clicking on the line corresponding to the desired product.<\/p>\n\n\n\n

Please also note that the Product Information does not in any way replace the advice of a doctor or pharmacist.<\/p>\n\n\n\n

Marketing authorization holders are represented by Merck Sharp & Dohme s.r.o. as a distributor for above mentioned medicinal products flagged as \u201climited availability\u201d in the Czech Republic.<\/p>\n\n\n\n

Information service for the blind and visually impaired is available at +420 233 010 111<\/a>.<\/p>\n\n\n\n

If you have any questions about a specific product from the MSD portfolio, please contact us at Merck Sharp & Dohme s.r.o., Na Valentince 3336\/4, 150 00 Prague 5, Czech Republic or by email at dpoc_czechslovak@merck.com<\/a> or phone +420 233 010 111<\/a>.<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n